Peptide-Based Hematological Disorders Therapeutics Market To Grow At 8.1% CAGR, Reaching US$ 1,253.9 Million By 2034
Advances in peptide drug development and the rising prevalence of hematological disorders are driving demand for peptide-based therapeu ...
Future Market Insights12h
Blow Fill Seal Technology Market Poised to Surge to USD 5,258.5 Million by 2033, Driven by Pharmaceutical Industry Adoption
The blow fill seal technology market is expected to grow from its estimated USD 3,107.8 million in 2024 to USD 5,258.5 million in 2034. Between 2024 and 2034, sales are expected to increase at a ...
Hosted on MSN20h
Global Incidence, Prevalence High for Genital Herpes Simplex Virus Infections
The incidence and prevalence of genital herpes simplex virus (HSV) type 1 and 2 infections are high worldwide, contributing ...
Barclays Remains a Hold on GlaxoSmithKline (GSK)
Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The ...
GSK Is Doing The Right Things But Can't Catch A Break - Rating Downgrade
GSK plc stock is downgraded due to litigation risks, weak sales, and market pressures, dividend yield remains a bright spot. Click for more on GSK stock.
FiercePharma2d
With Biktarvy patent cliff ahead, Gilead lays out a plan to keep the HIV crown with 7 launches through 2033
Gilead Sciences’ top money maker Biktarvy has been the company’s crown jewel for years now, but with the HIV med inching ...
Medscape3d
More Biologics May Be Breaking Through for COPD
Mepolizumab, a biologic approved for asthma, is not currently approved for COPD, but data from a 2017 study showed a trend ...
GlaxoSmithKline (GSK) Receives a Hold from Jefferies
Jefferies analyst Peter Welford maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today. The company’s shares opened today at ...
Cancellation of kids’ asthma medication continues to cause turmoil for Mass. families
Massachusetts families are still struggling to find alternatives almost a year after GlaxoSmithKline canceled a widely ...
Have A Drink On Maud Gatewood And Support Local Businesses In Blowing Rock, North Carolina
Maud Gatewood (1934–2004) is an essential figure in mid- and late-20th century art in North Carolina, both as an esteemed ...
Drugmaker AstraZeneca names new China chief to replace detained executive
British drugmaker AstraZeneca has appointed a new China head, replacing a former executive who has been detained by ...
East Boston9d
With Respiratory Season Arrival, DPH Reminds Patients and Providers of Alternatives to Discontinued Asthma Medication
The fall and winter season typically brings an increase in asthma exacerbations in Massachusetts. During this time, circulating respiratory illnesses, such as flu, RSV, and COVID increase, can ...